Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis
Status:
Not yet recruiting
Trial end date:
2023-04-30
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of ABCD in the treatment of cryptococcal meningitis in
non-HIV patients at week 4, the end of induction therapy, week 10 and the end of
consolidation therapy.
Phase:
N/A
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborator:
CSPC Ouyi Pharmaceutical Group Co., Ltd.
Treatments:
Amphotericin B Cholesteryl sulfate Fluconazole Flucytosine Liposomal amphotericin B